Metagenomi, Inc. (MGX)
NASDAQ: MGX · IEX Real-Time Price · USD
3.930
+0.050 (1.29%)
Jun 20, 2024, 2:24 PM EDT - Market open

Metagenomi Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
202320222021
Net Income
-68.26-43.59-21.44
Depreciation & Amortization
8.413.031.32
Share-Based Compensation
6.921.960.38
Other Operating Activities
-38.4968.3344
Operating Cash Flow
-91.4129.7224.26
Operating Cash Flow Growth
-22.54%-
Capital Expenditures
-9.81-13.98-2.9
Change in Investments
55.55-108.22-71.41
Investing Cash Flow
45.73-122.2-74.32
Share Issuance / Repurchase
-3.2800
Debt Issued / Paid
0029.97
Other Financing Activities
4.3239.599.95
Financing Cash Flow
1.01239.5939.92
Net Cash Flow
-44.66147.12-10.14
Free Cash Flow
-101.2215.7521.35
Free Cash Flow Growth
--26.26%-
Free Cash Flow Margin
-226.17%91.55%8787.65%
Free Cash Flow Per Share
-29.734.636.55
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).